Infection Control Find the newest stories covering infection and disease control in hospitals, care homes, and the general population. This section contains information on testing, monitoring, treatment options, vaccine development and distribution, as well as new policy decisions and best practices. Also included are announcements of educational and awareness campaigns. Follow new advances in infection control and prevention with releases about new study results and updated statistical data and analysis.

Latest Infection Control

23 May, 2017, 16:45 BST Infectious Disease Molecular Diagnostics Market Report 2017 - At the Height of the Influenza or Flu Season, up to 6% of all U.S. Outpatient Visits Can be for Influenza-like Illness - Research and Markets

Research and Markets has announced the addition of the "Infectious Disease Molecular Diagnostics Market (Hepatitis, HIV/CT/NG/HPV and Other...


23 May, 2017, 12:30 BST Dragonfly Therapeutics Adds Natural Killer Cell-Based Cancer Immunotherapy Expert to Its Scientific Advisory Board

Dr. Adelheid Cerwenka, professor at Heidelberg University and head of the Innate Immunity group in the German Cancer Research Center in Heidelberg,...


23 May, 2017, 10:00 BST Grifols Makes Procleix Zika Virus Assay Available for Screening Blood Donations to Countries Accepting CE Mark

- Grifols strengthens its Procleix portfolio with the CE marking for Procleix Zika Virus Assay - Blood banks in countries that accept the CE Mark*...


22 May, 2017, 10:30 BST Infection Control Market Size Worth $258.3 Billion by 2025: Grand View Research, Inc.

The global infection control market is expected to reach USD 258.3 billion by 2025, according to a new report by Grand View Research, Inc. The...


19 May, 2017, 11:45 BST Global Hepatitis C Disease Forecast and Market Analysis 2017-2035: Clinical Pipeline Overview, Marketed Drugs and Early-Phase Opportunities - Research and Markets

Research and Markets has announced the addition of the "Hepatitis C Disease Forecast and Market Analysis to 2035" report to their offering....


15 May, 2017, 08:30 BST EU Leaders Urge Funding of Critically-needed New Tools against Drug-resistant Tuberculosis - TB Alliance, TuBerculosis Vaccine Initiative and Deutsche Stiftung Weltbevölkerung High-Level Meeting

Participants at high-level meeting seek to end TB health threat in Europe Leaders from the governments of France and the Netherlands today...


01 May, 2017, 17:22 BST Terumo BCT Announces 2016 Advancing Apheresis Award Winner; Opens Applications for 2017

Terumo BCT funds a $10,000 USD grant to Aarhus University Hospital for solving venous access challenges Terumo BCT, a global medical device...


28 Apr, 2017, 07:00 BST Global Health Coalition Urges G20 Pledge on Pandemics and Neglected Diseases

A coalition of global health organisations has called on the G20 to provide leadership in combating pandemics, drug resistance, and major...


24 Apr, 2017, 13:08 BST BioGX Launches Four CE-marked IVD Assays at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

BioGX, a Birmingham Alabama based molecular diagnostics company, announced the launch of four additional CE-IVD infectious disease tests at the...


24 Apr, 2017, 00:01 BST Use of Extended-Pulsed Regimen with DIFICLIR[TM] (fidaxomicin) is More Effective Than Standard vancomycin in Achieving Sustained Cure of Clostridium difficile Infection (CDI) and Preventing Recurrence[1]

CDI, a potentially fatal disease,[2] is three times as deadly as MRSA[3],[4] and is estimated to cost the EU €3 billion per annum[5] New data...


21 Apr, 2017, 12:13 BST BioNet-Asia Organized International Pertussis Symposium Celebrating its 15th Anniversary in Bangkok

BANGKOK, April 21, 2017 /PRNewswire/ -- BioNet-Asia Co. Ltd organized the first International Symposium on Advances in Pertussis Immunisation...


21 Apr, 2017, 00:01 BST New Study Reveals the Impact of Clostridium difficile Infection (CDI) on the Health Service is Equivalent to an Additional 10,670 Bed Days a Year

CDI is one of the top ten hospital-acquired infections (HAIs) in European Hospitals[1] and is estimated to be three times as deadly as MRSA[2],[3]...


19 Apr, 2017, 17:05 BST Detact Diagnostics Receives €2.1M Investment from NOM Finance to Further Develop its Fast Bacterial Activity Test

The funding will support development of an innovative and patented technology platform for fast detection of bacterial activity Detact...


19 Apr, 2017, 12:00 BST MeMed Awarded $9.2m Contract by US Department Of Defense

Funds will be used to complete the development of first ever point of care platform to distinguish bacterial from viral infections MeMed Ltd....


17 Apr, 2017, 13:14 BST #MakingSchistory: Wormzilla Invades Lake Geneva

Experts gather at Neglected Tropical Diseases Summit to demand more global action to tackle one of the world's biggest killers - schistosomiasis...


10 Apr, 2017, 12:00 BST The Municipality of Santiago de Cali, Colombia, and Oxitec Ltd. Announce Memorandum to Deploy Friendly™ Aedes

Program to be implemented in Cali's Comuna 16 to fight wild Aedes aegypti, the mosquito that transmits Zika, dengue, chikungunya, Mayaro and...


30 Mar, 2017, 12:00 BST Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project

Level of suppression exceeds 80% for second consecutive year São Judas District has shown 78% reduction only six months after initial...


29 Mar, 2017, 15:30 BST Infectious Disease Drugs (2016-2021) - Analysis of 39 Statutory Communicable Diseases - Research and Markets

Research and Markets has announced the addition of the "Infectious Disease Drugs: The Chinese Market" report to their offering. The scope of the...


27 Mar, 2017, 07:00 BST Genedrive® HCV Assay Submitted for CE IVD Certification

Significant Step in Commercialisation of HCV Assay for Decentralised Use in Resource Limited Settings genedrive plc, the near patient molecular...


24 Mar, 2017, 04:01 GMT TB Alliance Sublicenses Promising Anti-tuberculosis Drug from the Medicines Patent Pool

Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer On...


22 Mar, 2017, 13:00 GMT PrimeStore® Molecular Transport Medium Aiding Laboratories Tracking H7N9 Avian Influenza

PrimeStore® MTM's pathogen inactivation and nucleic acid stabilization characteristics make it the ideal solution for transporting samples that...


15 Mar, 2017, 11:00 GMT Vtesse Completes Enrollment of Phase 2b/3 Pivotal Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease

Company anticipates sharing topline data and completing regulatory submissions in 2018 Vtesse, Inc. announced today that its registrational...


14 Mar, 2017, 17:27 GMT EuroBloodNet Aims for Better Care for Patients with Rare Blood Disorders

Patients suffering from rare blood disorders will benefit from networks of excellence across the European Member States. At the third...


08 Mar, 2017, 07:00 GMT Successful Clinical Results for Genedrive® HCV Assay

External Validation Studies Show Sensitivity of Greater Than 99% and Specificity of 100% for Hepatitis C Assay Designed for Decentralised Use in...


06 Mar, 2017, 08:00 GMT New Access to Vaccines Index Reveals First Landscape of Vaccine Company Actions to Improve Immunisation Coverage

The 2017 Access to Vaccines Index reveals the first landscape of industry activity to improve immunisation coverage. It finds high diversity in...